Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genotypic Resistance Guided Therapy for H. pylori
NCT01725906Phase 4Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- Nov 2012
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of esomeprazole, amoxicillin, metronidazole, levofloxacin, clarithromycin in Helicobacter pylori infection, sponsored by National Taiwan University Hospital. Status: unknown.
02
Drugs
esomeprazoleamoxicillinmetronidazolelevofloxacinclarithromycin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT01725906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01725906.